Viking Therapeutics, Inc (VKTX) Net Income by Year
Viking Therapeutics, Inc reported a net loss of $359.6M in fiscal year 2025. This represents a decrease of 227.1% from the prior fiscal year. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Viking Therapeutics, Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VKTX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
VKTX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Viking Therapeutics, Inc financials
Frequently Asked Questions
What was Viking Therapeutics, Inc's net income in fiscal year 2025?
Viking Therapeutics, Inc reported a net loss of $359.6M in fiscal year 2025.
How fast is Viking Therapeutics, Inc's net income growing?
Viking Therapeutics, Inc (VKTX) net income fell by 227.1% year over year, from -$110.0M to -$359.6M in fiscal year 2025.
What was Viking Therapeutics, Inc's net income in the most recent quarter?
Viking Therapeutics, Inc (VKTX) reported -$128.0M in net income in Q2 2026. This represents a decrease of 95.3% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Viking Therapeutics, Inc (VKTX) reported on that line in every period on record.